Exenatide Once Weekly Over 2 Years as a Potential Disease Modifying Treatment for Parkinson's Disease

Condition:   Parkinson's Disease Intervention:   Drug: Exenatide extended release 2mg subcutaneous injection (Bydureon) Sponsor:   University College, London Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials